Cover Page

About gist

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Editorial Commentary 
Advances in therapy of succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumor
Piotr Rutkowski, Maria Debiec-Rychter
Gastrointestinal Stromal Tumor  
2022;
5:
5  
Review Article 
New molecularly targeted drugs for gist after imatinib, sunitinib and regorafenib: a narrative review
Alessandro Mazzocca, Alessandro Minelli, Flavia Paternostro, Marianna Silletta, Andrea Napolitano, Bruno Vincenzi
Gastrointestinal Stromal Tumor  
2022;
5:
4  
Review Article 
Which is the Achilles heel of gastrointestinal stromal tumour and how to use it for the future?—a review of novel therapeutic paradigms
Iván Olivares-Rivas, Alfonso García-Valverde, César Serrano
Gastrointestinal Stromal Tumor  
2022;
5:
3  
Case Report 
Primary jejunal gastrointestinal stromal tumor in a patient with phakomatosis: a case report of an uncommon source of massive gastrointestinal hemorrhage
Ramon O. Minjares, Philippos A. Costa, Diego M. Montoya-Cerrillo, Luis E. Aguirre
Gastrointestinal Stromal Tumor  
2022;
5:
2  
Case Report 
Resection of a giant gastrointestinal stromal tumor after failed imatinib treatment during the COVID-19 pandemic: a case report
Katie Yusun Kwon, Facundo Iriarte, Heather Ann Hartman, Juhi Mittal, Antonio Di Carlo, Abbas El-Sayed Abbas
Gastrointestinal Stromal Tumor  
2022;
5:
1  
Review Article 
A narrative review of imatinib-resistant gastrointestinal stromal tumors
Yujiro Hayashi, Vy Truong Thuy Nguyen
Gastrointestinal Stromal Tumor  
2021;
5:
6  
Review Article 
A narrative review of surgical management of gastrointestinal stromal tumors
Iwona Kalinowska, Marcin Zdzienicki, Jacek Skoczylas, Piotr Rutkowski
Gastrointestinal Stromal Tumor  
2021;
5:
5  
Review Article 
Adjuvant therapy for primary GIST: is longer really better? A narrative review
Pamela W. Lu, Chandrajit P. Raut
Gastrointestinal Stromal Tumor  
2021;
5:
4  
Editorial Commentary 
Design your strategy, define your costs: third or subsequent-lines in advanced gastrointestinal stromal tumors (GIST)
Jacopo Giuliani
Gastrointestinal Stromal Tumor  
2021;
5:
3  
Editorial Commentary 
Ripretinib—a new star in the firmament
Attila Kollár
Gastrointestinal Stromal Tumor  
2021;
5:
2  
Case Report 
Dose escalation of ripretinib can lead to response in advanced gastrointestinal stromal tumor patients refractory to the standard dose: a report of two cases
Philippos Apolinario Costa, Caroline Kamal Abdelmessih Hana, Navin Chakravarthy Balaji, Anthony Frank Skryd, Brianna Nicole Valdes, Ramon O. Minjares, Priscila Barreto-Coelho, Andrea P. Espejo-Freire, Muhammad O. Hakim, Emily Jonczak, Ty Subhawong, Alan Livingstone, Jonathan C. Trent, Gina Z. D'Amato
Gastrointestinal Stromal Tumor  
2021;
5:
1  
Case Report 
Jejunal gastrointestinal stromal tumor (GIST): a case report presenting as life threatening emergency
Melissa Kyriakos Saad, Imad El Hajj, Elias Saikaly
Gastrointestinal Stromal Tumor  
2020;
5:
3  
Case Report 
Treatment of gastrointestinal stromal tumor with liver metastasis by surgery combined with imatinib in a male patient: a case report
Wenjun Xiong, Haipeng Huang, Yuling Xue, Jin Li, Jin Wan, Wei Wang
Gastrointestinal Stromal Tumor  
2020;
5:
2  
Original Article 
Novel association between Helicobacter pylori infection and gastrointestinal stromal tumors (GIST) in a multi-ethnic population
Jaclyn Kagihara, Brent Matsuda, Kraig L. Young, Xiufen Li, Xuegang Lao, Gautam A. Deshpande, Fumio Omata, Terrilea Burnett, Charles F. Lynch, Brenda Y. Hernandez, Scott K. Kuwada
Gastrointestinal Stromal Tumor  
2020;
5:
1  
News 
Application of the CARE guideline as reporting standard in the Gastrointestinal Stromal Tumor
Editorial Office
Gastrointestinal Stromal Tumor  
2019;
5:
5  
Editorial Commentary 
Advancing the promises of precision medicine for patients with gastrointestinal stromal tumor
Joaquina C. Baranda, Andrew K. Godwin
Gastrointestinal Stromal Tumor  
2019;
5:
4  
Editorial 
Avapritinib: preclinical studies of a promising novel therapeutic option for gastrointestinal stromal tumors
Milena Urbini
Gastrointestinal Stromal Tumor  
2019;
5:
3  
Images in Clinical Medicine 
Gastrointestinal stromal tumor with a platelet-derived growth factor receptor-alpha mutation
Tatsuo Kanda, Takashi Ishikawa, Takahiro Taguchi
Gastrointestinal Stromal Tumor  
2019;
5:
2  
Editorial 
A new promising quinazoline-derived Pan-KIT mutant inhibitor for the gastrointestinal stromal tumors (GIST) management
Nathália C. Campanella, Viviane A. O. Silva, Rui Manuel Reis
Gastrointestinal Stromal Tumor  
2018;
5:
4